Your completely INDEPENDENT source of news and information about the new insulin delivery system named Exubra.
This news website is absolutely NOT affiliated with NOR endorsed by the owners of the trademark Exubera (Pfizer or Aventis), which developed Exubra™.
8/14/05: A Postponement
The Food and Drug Aministration announced that is extending its period of review for Exubera (inhaled insulin) to look over more data submitted by the makers of Exubera.
If Exubera is approved, many diabetics can inhale their insulin instead of injecting it to control blood sugar. This delay will delay the launch of the drug, too. Many diabetics are looking forward to Exubera's approval so they won't have to take daily insulin shots.
Nektar
Therapeutics, Pfizer
and Sanofi-Aventis
together are developing and will promote Exubera. Exubera was
recommended for approval by an internal committee of the FDA in September,
and while the FDA doesn't have to follow the recommendations of its
committee, it usually does.
Pfizer
and Sanofi-Aventis
want to make totally sure that diabetics won't have a problem with
decreased lung capacity. In studies, while there was a small
decrease in a patient's lung capacity at first for just a few weeks, the
changes did not get worse over the next two years and went back to normal
if the patient when the patient stopped using Exubera.
If or when Exubera is approved by the
FDA, diabetics just have to inhale Exubera before a meal. It works
like the body's usual repsonse to food and reduces spikes in blood sugar
levels in diabetics. Diabetes is a
disease that's becoming an epidemic. Almost 200 people have it and
in 20 years it could be 300 million. In Europe alone, over 20
million people have diabetes, and type 2 affects 9 out of 10 of those
patients.
 We
subscribe to the HONcode principles of the HON Foundation.
|
This is an absolutely independent news site reporting on Exubera, an insulin delivery system developed by Pfizer or Aventis, which plans to market it under the trademarked name Exubera. Nothing on this website is intended to infringe on that trademark in any way nor is anything on this website is intended to be medical advice. All information provided here is just to be used for informational purposes. Note that you should always consult a doctor with any questions you may have regarding a medical condition. |
Copyright
2005 Diabetes Report. All rights reserved.
Last updated on 9/24/05 |
The Exubera Report on Diabetes Inhaler